GoodCap Pharmaceuticals Inc. is a Canadian healthcare startup dedicated to developing psilocybin-based therapeutics. The company, founded in 2021, focuses on harnessing the health benefits of mushrooms and their compounds. GoodCap leads in the formulation, research, and development of psilocybin-based therapeutic products, specifically targeting inflammatory disorders and mental health conditions. As a life sciences company, GoodCap is at the forefront of discovering natural therapies. Currently, there is no publicly disclosed information about their latest investment.
There is no investment information
No recent news or press coverage available for GoodCap Pharmaceuticals Inc..